Oslo Cancer Cluster – From cancer research to cure
Oslo Cancer Cluster is a research– and industry cluster within the field of cancer, in the Oslo–region of Norway, established as a result of more than 80 years of excellence in cancer research. The Norwegian government has appointed Oslo Cancer Cluster as a Norwegian Centre of Expertise (NCE). Oslo Cancer Cluster NCE is a non–profit organization with broad public funding and support.
Oslo Cancer Cluster is solely focused on developing new cancer treatments and diagnostics for the benefit of cancer patients. The cluster works to accelerate development of new cancer diagnostics and treatment.
Ten percent of the world’s cancer products
Oslo Cancer Cluster fuses together Norway’s world–class cancer research, unique healthcare infrastructure such as the Cancer Registry and the biobanks, with innovative biotechnology companies. Oslo Cancer Cluster´s member companies are strong in product development with over 50 products in clinical trials, ten percent of the overall cancer products in clinical trials worldwide. “We have more than 50 members from the government, research institutions, patient organisations, life sciences industry and hospitals. Our members come from the whole of Norway and abroad”, says CEO Bjarte Reve.
Innovation Park in 2012
In August 2008 Oslo Cancer Cluster signed an agreement with the Oslo Council to build the Oslo Cancer Cluster Innovation Park next to the Radium Hospital. The Park is due for completion July 2012. It will include an incubator, AstraZeneca, GSK and biotechs, the Norwegian Cancer Registry, biobanks, the phase 1 unit at the Radium hospital and a fully integrated High School.
